HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection

Science

Volumn 305, Issue 5685, 2004, Pages 872-874

  Khakoo, Salim I ^a   Thio, Chloe L ^b   Martin, Maureen P ^c   Brooks, Collin R ^a   Gao, Xiaojiang ^c   Astemborski, Jacquie ^b   Cheng, Jie ^c   Goedert, James J ^d   Vlahov, David ^e   Hilgartner, Margaret ^f   Cox, Steven ^g   Little, Ann Margeret ^g   Alexander, Graeme J ^h   Cramp, Matthew E ⁱ   O'Brien, Stephen J ^j   Rosenberg, William M C ^a   Thomas, David L ^b   Carrington, Mary ^c  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c SAIC FREDERICK INC   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e NEW YORK ACADEMY OF MEDICINE   (United States)

^f WEILL CORNELL MEDICAL CENTER   (United States)

^g ROYAL FREE HOSPITAL   (United Kingdom)

^h UNIVERSITY OF CAMBRIDGE   (United Kingdom)

ⁱ DERRIFORD HOSPITAL   (United Kingdom)

^j NATIONAL CANCER INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; CELLS; DATA REDUCTION; IMMUNOLOGY; MOLECULAR STRUCTURE; VIRUSES;

GENE ENCODING; HEPATITIS C VIRUS (HCV) INFECTION; LIGANDS; NATURAL KILLER (NK) CELLS;

GENETIC ENGINEERING;

CELL RECEPTOR; HLA ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER CELL RECEPTOR KIR2DL3; UNCLASSIFIED DRUG;

MEDICINE;

AFRICAN AMERICAN; ARTICLE; CAUCASIAN; GENE FREQUENCY; HEPATITIS C; HEREDITY; HLA SYSTEM; HUMAN; IMMUNE RESPONSE; NATURAL KILLER CELL; PRIORITY JOURNAL; RECEPTOR GENE; VIRUS INFECTION;

ADOLESCENT; ADULT; AFRICAN AMERICANS; ALLELES; BLOOD TRANSFUSION; CHILD; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEPACIVIRUS; HEPATITIS C; HLA-C ANTIGENS; HOMOZYGOTE; HUMANS; KILLER CELLS, NATURAL; LIGANDS; MALE; RECEPTORS, IMMUNOLOGIC; REGRESSION ANALYSIS;

HEPATITIS C VIRUS;

EID: 3843075120     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.1097670     Document Type: Article

References (25)

1. H. G. Ljunggren, K. Karre, Immunol. Today 11, 237 (1990).
2. N. M. Valiante et al., Immunity 7, 739 (1997).
3. S. Bauer et al., Science 285, 7Z7 (1999).
4. K. Karre, H. G. Ljunggren, G. Piontek, R. Kiessling, Nature 319, 675 (1986).
5. K. L. Hershberger, R. Shyam, A. Miura, N. L. Letvin, J. Immunol. 166, 4380 (2001).
6. S. I. Khakoo et al., Immunity 12, 687 (2000).
7. M. Uhrberg et al., Immunity 7, 753 (1997).
8. M. P. Martin et al., J. Immunol. 169, 2818 (2002).
9. M. P. Martin et al., Nature Genet. 31, 429 (2002).
10. J. H Yen et al., J. Exp. Med. 193, 1159 (2001).
11. V. Racanelli, B. Rehermann, Trends Immunol. 24, 456 (2003).
12. C. L. Thio et al., J. Virol. 76, 4792 (2002).
13. S. Crotta et al., J. Exp. Med. 195, 35 (2002).
14. C. B. Bigger, K. M. Brasky, R. E. Lanford, J. Virol. 75, 7059 (2001).
15. Materials and methods are available as supporting material on Science Online.
16. C. C. Winter, J. E. Gumperz, P. Parham, E. O. Long, N. Wagtmann, J. Immunol. 161, 571 (1998).
17. H. Arase, E. Mocarski, A. E. Campbell, A. B. Hill, L. L. Lanie Science 296, 1323 (2002).
18. A. A. Scalzo, N. A. Fitzgerald, A. Sim, G. R. Shellam, J. Exp. Med. 171, 1469 (1990).
19. P. Simmonds et al., Lancet 336, 1469 (1990).
20. Z. P. Guo, M. W. Yu, Transfusion 35, 112 (1995).
21. D. L. Thomas et al. JAMA 284, 450 (2000).
22. H. G. Shilling et al., J. Immunol. 169, 239 (2002).
23. F. Colucci, J. P. Di Santo, P. J. Leibson, Nature Immunol. 3, 807 (2002).
24. E. J. Adams, G. Thomson, P. Parham, Immunogenetics 49, 865 (1999).
25. We would like to acknowledge the many individuals who assisted in collecting samples, the research participants, health care providers, and P. Karacki and J.-H. Lee for technical assistance. This publication has been funded in part with funds from the National Cancer Institute, National Institutes of Health, under contracts NO1-CO-12400, N01-CP-33002, and N01-CP-01004; NIH grants DA00441, DA04334, and DA13324; the Bureau of Maternal and Child Health and Resources Development (MCJ-060570); the National Institute of Child Health and Human Development (NO1-HD-4-3200); the Centers for Disease Control and Prevention; the National Institute of Mental Health; the Medical Research Council (UK); Hope Charity; and the National Health Service (UK) research and development program. The content of this publication does not necessarily reflect the views or policies of the U.S. Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. government.